Cargando…
A novel strategy to block mitotic progression for targeted therapy
BACKGROUND: Blockade of mitotic progression is an ideal approach to induce mitotic catastrophe that suppresses cancer cell expansion. Cdc20 is a critical mitotic factor governing anaphase initiation and the exit from mitosis through recruiting substrates to APC/C for degradation. Results from recent...
Autores principales: | Chi, Junlong (Jack), Li, Hongchun, Zhou, Zhuan, Izquierdo-Ferrer, Javier, Xue, Yifan, Wavelet, Cindy M., Schiltz, Gary E., Zhang, Bin, Cristofanilli, Massimo, Lu, Xinghua, Bahar, Ivet, Wan, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945239/ https://www.ncbi.nlm.nih.gov/pubmed/31669221 http://dx.doi.org/10.1016/j.ebiom.2019.10.013 |
Ejemplares similares
-
CDC20-Mediated hnRNPU Ubiquitination Regulates Chromatin Condensation and Anti-Cancer Drug Response
por: Wavelet-Vermuse, Cindy, et al.
Publicado: (2022) -
New insight into the significance of KLF4 PARylation in genome stability, carcinogenesis, and therapy
por: Zhou, Zhuan, et al.
Publicado: (2020) -
A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy
por: Zhou, Zhuan, et al.
Publicado: (2019) -
Quantitative Systems Pharmacological Analysis of Drugs of Abuse Reveals the Pleiotropy of Their Targets and the Effector Role of mTORC1
por: Pei, Fen, et al.
Publicado: (2019) -
QuartataWeb: Integrated Chemical–Protein-Pathway Mapping for Polypharmacology and Chemogenomics
por: Li, Hongchun, et al.
Publicado: (2020)